FDA
GAO Report Highlights Ambiguities in DEA and FDA Drug Scheduling Decisions
A Government Accountability Office report notes that the criteria used by the DEA and FDA to place substances in controlled‑substance schedules are not clearly defined in the Controlled Substances Act, leading to…
1 source36 claims checked1mo ago
31 unverifiable5 mostly supported
Biblical perspectiveINSUFFICIENT CONTEXT
Full analysis